References
- Kontoyiannis DP, Lionakis MS, Lewis RE, . Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Inf Dis 2005; 191: 1350–1360.
- Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006; 25: 215–229.
- Roden MM, Zaoutis TE, Buchanan WL, . Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634–653.
- Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin MicrobiolRev 2000; 13: 236–301.
- Lussier N, Laverdiere M, Weiss K, Poirier L, Schick E. Primary renal mucormycosis. Urology 1998; 52: 900–903.
- Weng DE, Wilson WH, Little R, Walsh TJ. Successful medical management of isolated renal zygomycosis: case report and review. Clin Infect Dis 1998; 26: 601–605.
- Sampol BJ. Obstructive fungus ball in kidney allografts. Actas Urol Esp 2008; 32: 267.
- Wimalendra M, Reece A, Nicholl RM. Renal fungal ball. Arch Dis Child Fetal Neonatal Ed 2004; 89: F376.
- Roehrl MH, Croft WJ, Liao Q, Wang JY, Kradin RL. Hemorrhagic pulmonary oxalosis secondary to a noninvasive Aspergillus niger fungus ball. Virchows Arch 2007; 451: 1067–1073.
- Wingard JR CS, Walsh TJ, Kurtzberg J, . Results of fluconazole (FLU) vs voriconazole (VORI) for the prevention of invasive fungal infections (IFI) in 600 allogeneic blood and marrow transplant (BMT) patients. Blood 2007; 110: 55a. Abstract #163.
- Arikan S, Sancak B, Alp S, Hascelik G, McNicholas P. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus. Med Mycol 2008; 46: 567–573.
- Notheis G, Tarani L, Costantino F, . Posaconazole for treatment of refractory invasive fungal disease. Mycoses 2006; 49 (Suppl. 1): 37–41.
- Yu J, Li RY. Primary renal zygomycosis due to Rhizopus oryzae. Med Mycol 2006; 44: 461–466.
- Pappas PG, Kauffman CA, Andes D, . Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503–535.
- Irby PB, Stoller ML, McAninch JW. Fungal bezoars of the upper urinary tract. J Urol 1990; 143: 447–451.
- Ortiz O, Lee WJ. Percutaneous nephrostomy in the management of renal candidiasis. Arch Surg 1989; 124: 739–740.
- Govitrapong P, Suttitum T, Kotchabhakdi N, Uneklabh T. Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J Pharmacol Exp Ther 1998; 286: 883–889.
- Greenberg RN, Mullane K, van Burik JA, . Posaconazole as salvage therapy for zygomycosis. Antimicrob AgentsChemother 2006; 50: 126–133.
- van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006; 42: e61–65.
- Posaconazole [package insert]. Kenilworth NSC.